Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Impact and Interventions Related to FDASIA: Increasing Diversity in Clinical Trials
Track : Track 01: Clinical Operations
Program Code: 419
Date: Thursday, June 27, 2013
Time: 10:45 AM to 12:15 PM  EST
Location: 153AB
CHAIR :
 Brenda Jamerson, Campbell University College of Pharmacy and Health Sciences, United States
SPEAKER (S):
Brenda Jamerson, PharmD (SCHSUP), Associate Professor, Clinical Research, Campbell University College of Pharmacy and Health Sciences, United States
 Almenia K. Garvey, MSc (SPKNON), Senior Clinical Feasibility Leader, PAREXEL International, United States
Rebecca Lynn Budd, (SPKNON), Managing Director, Navita Clinical Strategy Group, United States
Description
This symposium will provide an overview of the FDA Safety and Innovation Act (FDASIA) addressing the challenges and strategies related to increasing minority enrollment in clinical trials and the strategies that may facilitate comprehension of Informed Consent.

Session Recording
(Code: 419)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON5 Comp Access: Thursday Online Access Package - June 27, 2013
Handout Online
(Code: 419)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON5 Comp Access: Thursday Online Access Package - June 27, 2013
Impact and Interventions Related to FDASIA: Increasing Diversity in Clinical Trials